CT imaging company CurveBeam revealed on Monday the receipt of the US FDA's 510(k) clearance for its LineUP Multi-extremity weight bearing CT system for launch in the orthopedic extremity imaging market.
The company said the compact system enables radiologists and orthopedic specialists to visualize three-dimensional bone detail of the lower extremities, while the patient is standing, so anatomy can be assessed while in the "weight bearing" or "load bearing" position.
In conjunction, the LineUP can perform bilateral scans of entire legs, the hand, wrist as well as elbow The LineUP system can be plugged into a standard wall outlet and has minimal shielding requirements. Radiation dose to the patient is significantly less than a conventional CT scan.
According to the company, the weight bearing CT imaging for body extremities became commercially available in 2012. The device has been added to the imaging services of numerous hospital foot & ankle sections, orthopedic clinics and podiatry offices worldwide. Its InReach system for hand, wrist and elbow received FDA clearance in 2017. Specialists extol the ability to confirm a scaphoid fracture diagnosis or distal radius fracture diagnosis at the point-of-care.
Rigel Pharmaceuticals begins dose expansion phase of R289 study in lower-risk MDS
Precision NeuroMed's glioblastoma multiforme treatment granted FDA Orphan Drug Designation
Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio
Oxford Biomedica expands US operations with acquisition of viral vector facility in North Carolina
DarioHealth and OneStep partner to integrate fall risk technology into digital health platform
Ananda Pharma achieves key Phase 1 milestone for MRX1 CBD program
Alvotech and Advanz Pharma announce EMA acceptance of AVT23 marketing application
Polarean expands Ascend Imaging partnership to boost US market reach
Alto Neuroscience receives FDA Fast Track designation for ALTO-101
Calico Life Sciences' investigational treatment for ADPKD receives US FDA Fast Track Designation
Hologic receives FDA clearance and CE mark for new gastrointestinal bacterial assays
Celltrion launches AVTOZMA IV in the United States following FDA approval
Vanda Pharmaceuticals agrees collaborative framework to resolve US FDA disputes